Bellicum Pharmaceuticals, Inc.
生物技术研究
Houston，Texas 9,488 位关注者
Bellicum is a clinical-stage biopharmaceutical company that is driving the future of celluar IO.
关于我们
Bellicum Pharmaceuticals, located near the Houston Medical Center, is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever. Our cellular platform technology is designed to break through significant clinical barriers and activate the full power of cellular immunotherapies, with a focus on chimeric antigen receptor T-cell therapy (CAR-T).
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Houston，Texas
- 类型
- 上市公司
- 创立
- 2003
- 领域
- Oncology、Cell Therapy、Immunotherapy、CAR-T和Biopharmaceutical
地点
-
主要
获取路线
3730 Kirby Dr
Suite 1200
US，Texas，Houston，77098
Bellicum Pharmaceuticals, Inc.员工
-
Scott Jordan
Experienced contract manufacturing leader in biopharmaceutical industry / MBA
-
Kevin Slawin MD
Founder and CEO, SENOTHERAPEUTIX, Inc., a longevity company developing novel senolytic and senomorphic therapeutics that target the fundamental…
-
Julia Aylward
Behind the scenes members of the board of directors at Bellicum Pharmaceuticals, Inc.
-
Eric Yvon
Associate Professor at The George Washington University School of Medicine and Health Sciences